A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial

OBJECTIVES: We aimed to test our hypothesis that additional administration of traditional Japanese (Kampo) medicine, kakkonto (kakkon-to: KT) and shosaikotokakikyosekko (sho-saiko-to-ka-kikyo-sekko: SSKKS), is more effective in relieving symptoms and preventing the onset of severe infection in mild-...

Descripción completa

Detalles Bibliográficos
Autores principales: Takayama, Shin, Namiki, Takao, Ito, Takashi, Arita, Ryutaro, Nakae, Hajime, Kobayashi, Seiichi, Yoshino, Tetsuhiro, Ishigami, Tomoaki, Tanaka, Koichiro, Kainuma, Mosaburo, Nochioka, Kotaro, Takagi, Airi, Mimura, Masaru, Yamaguchi, Takuhiro, Ishii, Tadashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530547/
https://www.ncbi.nlm.nih.gov/pubmed/33008479
http://dx.doi.org/10.1186/s13063-020-04746-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530547/
https://www.ncbi.nlm.nih.gov/pubmed/33008479
http://dx.doi.org/10.1186/s13063-020-04746-9

Ejemplares similares